Pinnacle Food Group Limited Completes Key Development Milestone and Commences Construction of Commercial-Scale Microalgae-Based Astaxanthin Facility in Canada

Rhea-AI Summary

Pinnacle Food Group (Nasdaq:PFAI) announced it has completed a key development milestone and begun on-site construction of a commercial-scale, microalgae-based astaxanthin production facility for Bei Harvest in British Columbia, Canada.

According to the company, the turnkey project is structured in phases and is expected to generate aggregate revenue of approximately US$10 million, subject to final scope and execution. Phase I, covering planning and development, is valued at about US$4 million, while Phase II, covering construction, is valued at about US$6 million. Pinnacle Food is acting as project developer and general contractor, overseeing design, engineering, construction and systems integration.

The facility is expected to use advanced photobioreactor cultivation systems in a fully enclosed, precision-controlled environment for commercial microalgae cultivation. Management said the milestone supports Pinnacle Food’s strategic expansion into biomanufacturing and further develops its business-to-business technology and project-delivery platform.

Positive

• US$10 million expected aggregate project revenue from Bei Harvest facility
• Phase I planning and development valued at about US$4 million
• Phase II construction phase valued at about US$6 million
• Project advances strategic expansion into biomanufacturing and B2B platform

Negative

• None.

Market reaction: PFAI +4.77% on astaxanthin facility construction milestone

+4.77% 1.9x vol

1 alert

+4.77% News Effect

+$2M Valuation Impact

$43.43M Market Cap

1.9x Rel. Volume

On the day this news was published, PFAI gained 4.77%, reflecting a moderate positive market reaction. This price movement added approximately $2M to the company's valuation, bringing the market cap to $43.43M at that time. Trading volume was above average at 1.9x the daily average, suggesting increased trading activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Set against a recent annual net loss of US$1.9 million and cash of US$0.9 million, this construction...

Analysis

Set against a recent annual net loss of US$1.9 million and cash of US$0.9 million, this construction milestone highlights execution progress but not yet balance-sheet relief. With short interest described as low, attention may stay on funding needs and contract conversion.

Key Figures

Project revenue: US$10 million Phase I value: US$4 million Phase II value: US$6 million +4 more

7 metrics

Project revenue US$10 million Aggregate expected revenue from Bei Harvest facility project

Phase I value US$4 million Planning and development phase of Bei Harvest facility

Phase II value US$6 million Construction phase of Bei Harvest facility

Net loss US$1.9 million Year ended December 31, 2025 (20-F)

Accumulated deficit US$1.1 million As of December 31, 2025 (20-F)

Cash balance US$0.9 million As of December 31, 2025 (20-F)

Current liabilities US$2.4 million As of December 31, 2025 (20-F)

Historical Context

5 past events · Latest: Jun 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 05	CFO transition	Neutral	+5.8%	Company replaced its CFO, emphasizing public-company reporting and IPO experience.
Apr 20	Strategic MOU	Positive	+2.3%	Subsidiary signed non-binding MOU for an Open Yeast Platform hub in Hong Kong.
Apr 15	Technical breakthrough	Positive	+1.0%	Announced methanol-free Pichia fermentation method for recombinant human lactoferrin.
Mar 13	Investor Day recap	Positive	-3.3%	Highlighted Dual-Engine strategy, rhLF commercialization path, and M&A consolidation plans.
Mar 02	Investor Day notice	Neutral	+2.2%	Scheduled virtual Investor Day 2026 and non-deal roadshow for global investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent corporate and technical updates have more often been followed by modestly positive price reactions than by negative ones.

Key Terms

astaxanthin, photobioreactor, precision fermentation, synthetic biology

4 terms

astaxanthin medical

"commercial-scale microalgae-based astaxanthin production facility for Bei Harvest"

Astaxanthin is a red pigment and powerful antioxidant produced by certain algae and microbes, often sold as a dietary supplement or used as a colorant in aquaculture and cosmetics. Investors care because its demand, production method (natural vs. synthetic), regulatory approvals, and supply costs directly affect sales, margins and growth potential—think of it as a specialty ingredient whose price and quality can make or break a product line.

photobioreactor technical

"expected to incorporate advanced photobioreactor ("PBR") cultivation systems"

A photobioreactor is a closed, controlled system that grows photosynthetic organisms—like algae or cyanobacteria—by supplying light, nutrients, temperature control, and gas exchange. For investors, it matters because these systems determine how efficiently and predictably biological products (biofuels, animal feed, nutritional compounds, or carbon-capture biomass) can be produced at scale; think of it as a greenhouse with precise lab controls that affects output, cost and regulatory compliance.

precision fermentation technical

"combine controlled-environment agricultural technologies with precision fermentation"

Precision fermentation uses edited microbes (like yeast or bacteria) as tiny, programmable factories to produce a single, specific ingredient—such as a protein, enzyme or flavor—rather than making whole foods. Think of it like coding a vending machine to dispense one exact product on demand. For investors, it matters because it can cut production costs, speed up scale-up, reduce reliance on traditional agriculture or chemical synthesis, and create new, high-margin products that can reshape markets and regulatory pathways.

synthetic biology technical

"combine controlled-environment agricultural technologies with precision fermentation, synthetic biology"

Synthetic biology is the design and construction of new or modified living systems—like reprogramming cells or microbes—to perform useful tasks such as making materials, medicines, or fuels. For investors it signals a platform technology with potential for high growth and disruption, similar to how software transformed industries: early breakthroughs can create new markets, long-term revenue streams, and also carry technical, regulatory, and ethical risks that affect valuation and timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

VANCOUVER, BC / ACCESS Newswire / July 15, 2026 / Pinnacle Food Group Limited (Nasdaq:PFAI) ("Pinnacle Food" or the "Company"), a technology-driven company operating at the intersection of smart farming and bioengineering, today announced the completion of a key project development milestone and the formal commencement of construction of a commercial-scale microalgae-based astaxanthin production facility for Bei Harvest Ltd. ("Bei Harvest") in British Columbia, Canada.

In April 2026, Pinnacle Food entered into an agreement with Bei Harvest for the phased development and delivery of a turnkey facility designed to support the commercial cultivation of microalgae and the production of astaxanthin. Astaxanthin is a naturally occurring carotenoid used in dietary supplements, functional foods, cosmetics and other applications.

The aggregate revenue for the Company from the project is expected to be approximately US$10 million, subject to the final project scope and execution. Phase I, which encompasses planning and development, is valued at approximately US$4 million, as previously disclosed in the Company's 2025 Annual Report. Phase II, which encompasses construction of the project, is valued at approximately US$6 million.

As the project developer and general contractor, Pinnacle Food is responsible for coordinating the facility's design, engineering, construction and systems integration. The facility is expected to incorporate advanced photobioreactor ("PBR") cultivation systems within a fully enclosed, precision-controlled environment designed for commercial-scale microalgae cultivation. The completion of the applicable planning and design work has enabled the project to transition into on-site construction.

"The transition from technical planning and development to on-site construction represents an important milestone for both Pinnacle Food and Bei Harvest," said Jiulong You, Chief Executive Officer of Pinnacle Food Group Limited. "This project demonstrates our ability to integrate controlled-environment cultivation, engineering and biomanufacturing technologies into commercial infrastructure for the production of high-value biological products."

"This milestone also advances our strategic expansion into biomanufacturing," Mr. You continued. "By applying our experience in precision-controlled growing environments to commercial microalgae cultivation and astaxanthin production, we aim to help our partners establish scalable production capabilities while further developing Pinnacle Food's business-to-business technology and project-delivery platform."

About Pinnacle Food Group Limited

Pinnacle Food Group Limited (Nasdaq: PFAI) is a technology-driven company operating at the intersection of smart farming and bioengineering. Through its "Dual-Engine" strategy, the Company seeks to combine controlled-environment agricultural technologies with precision fermentation, synthetic biology and related engineering capabilities to support the development and commercialization of high-value biological products. For more information, please visit the Company's website at www.pinnaclefoodinc.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. federal securities laws. These statements include, but are not limited to, statements regarding the development, construction, installation, commissioning and future operation of the proposed microalgae-based astaxanthin production facility; the anticipated features, capabilities and performance of the facility and its cultivation systems; the timing and completion of Phase I and subsequent stages; the ability of the project to support commercial-scale microalgae cultivation and astaxanthin production; potential demand for astaxanthin and related biological products; and the Company's expansion into biomanufacturing.

Forward-looking statements are based on current expectations, estimates and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, among others, construction delays and cost overruns; the availability and timely delivery of equipment and materials; installation and commissioning challenges; the receipt and maintenance of required permits and regulatory approvals; the ability to achieve anticipated cultivation yields, production output and operating performance; counterparty and financing risks; supply chain disruptions; changes in market demand and pricing; and broader economic and industry conditions.

Readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Investor and Media Contact

Pinnacle Food Group Limited
Email: ir@pinnaclefoodinc.com

SOURCE: Pinnacle Food Group Limited

View the original press release on ACCESS Newswire

FAQ

What did Pinnacle Food Group (PFAI) announce on July 15, 2026?

Pinnacle Food Group announced completion of a key development milestone and the start of construction on a commercial-scale microalgae-based astaxanthin facility for Bei Harvest in Canada. According to Pinnacle Food, this follows Phase I planning and moves the project into on-site execution.

How much revenue is Pinnacle Food Group (PFAI) expecting from the Bei Harvest astaxanthin project?

Pinnacle Food expects aggregate project revenue of about US$10 million, subject to final scope and execution. According to Pinnacle Food, Phase I planning and development is valued at about US$4 million and Phase II construction at about US$6 million.

What is the role of Pinnacle Food Group (PFAI) in the Bei Harvest microalgae facility?

Pinnacle Food is project developer and general contractor for the Bei Harvest facility. According to Pinnacle Food, it coordinates design, engineering, construction and systems integration, including advanced photobioreactor systems in a fully enclosed, precision-controlled cultivation environment.

How does the Bei Harvest astaxanthin facility support Pinnacle Food Group’s (PFAI) strategy?

The facility milestone supports Pinnacle Food’s strategic expansion into biomanufacturing and B2B project delivery. According to Pinnacle Food, it applies controlled-environment growing experience to commercial microalgae cultivation and astaxanthin production, aligning with its “Dual-Engine” strategy in smart farming and bioengineering.

What technologies will Pinnacle Food Group (PFAI) use in the new astaxanthin facility in Canada?

The facility is expected to use advanced photobioreactor cultivation systems within a fully enclosed, precision-controlled environment. According to Pinnacle Food, these systems are designed for commercial-scale microalgae cultivation to produce astaxanthin for supplements, functional foods, cosmetics and other applications.

Who is Bei Harvest in Pinnacle Food Group’s (PFAI) July 2026 project announcement?

Bei Harvest is the customer for which Pinnacle Food is developing a turnkey commercial-scale microalgae-based astaxanthin facility. According to Pinnacle Food, the agreement covers phased development, from planning and design through construction and systems integration in British Columbia, Canada.